On September 17, Shanghai Unicornshell Pharmaceutical Technology Co., Ltd. was invited to participate in the 22nd China-ASEAN Expo held in Nanning, Guangxi. During the expo, Unicornshell engaged in in‑depth exchanges with merchants from ASEAN countries, and the Chongzuo Integrated Media Center conducted a special report on the company's core products. In the future, Unicornshell will also sign a strategic cooperation agreement with Chongzuo City to jointly promote the upgrading of the green pharmaceutical industry.

This expo, co‑hosted by the Ministry of Commerce of China, the governments of ten ASEAN countries, and the ASEAN Secretariat, is themed "Cooperation and Win‑Win, Building a Modern Economic System". It focuses on digital economy, green industries, and healthcare, attracting thousands of enterprises from over 40 countries and regions. On this high‑level international stage, Unicornshell demonstrated the technological strength and development potential of Chinese pharmaceutical enterprises with its innovative achievements in HPMC pharmaceutical excipients.

Headquartered in Shanghai, Unicornshell focuses on the R&D, production, and sales of HPMC pharmaceutical excipients and innovative traditional Chinese medicine (TCM) formulations. It has launched hypromellose (HPMC) capsules (first generation) and hydroxypropyl starch capsules (second generation), which are widely used in pharmaceuticals and nutraceuticals. Through an industrial cluster model, the company promotes the deep integration of intelligent manufacturing and new materials, empowering the transformation and upgrading of the traditional pharmaceutical industry, and striving to become a leader in the intelligent manufacturing of HPMC capsules.

At the expo, Unicornshell prominently featured its HPMC empty capsules and a series of innovative formulations, including new products such as ganoderma spore powder capsules. Thanks to their green environmental protection and excellent performance, they attracted the attention of many domestic and international merchants, leading to multiple cooperation intentions. Merchants from ASEAN countries such as Singapore, Indonesia, and Malaysia showed strong interest in the product performance and international certification advantages. As a company that has obtained US FDA, Halal, European BRC, GMP, and Kosher certifications, Unicornshell possesses core competitiveness for international market access, laying a solid foundation for further expansion into ASEAN and Belt and Road markets.

Meanwhile, the Chongzuo Integrated Media Center conducted a special report on Unicornshell, introducing the company's technological innovation and international layout in the field of HPMC capsules. After the expo, Unicornshell will formally sign a strategic cooperation agreement with Chongzuo City, focusing on green pharmaceutical industry development and investment promotion, to support high‑quality local economic development.

In the future, Unicornshell will continue to uphold its mission of "promoting medication safety and protecting human health", seize new opportunities in China-ASEAN cooperation, leverage its technological advantages and international certification strengths in the field of HPMC pharmaceutical excipients, accelerate overseas market expansion, and promote the implementation of innovative achievements in ASEAN and Central Asian markets. With a more open attitude, the company will join hands with regional partners to build a green and safe pharmaceutical excipient ecosystem, creating a new pattern of mutual benefit and win‑win cooperation.